Oxford Science Enterprises Overview
- Investor Type
- University
- Status
- Active
- Professionals
- 15
- Investments
- 168
- Portfolio
- 72
- Exits
- 10
Oxford Science Enterprises General Information
Description
Founded in 2015, Oxford Science Enterprises is a university-backed investment firm based in Oxford, United Kingdom. The firm seeks to invest in early-stage companies operating in the life sciences, deep tech, health tech, artificial intelligence, and software sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
University
Primary Office
- 46 Woodstock Road
- Oxford OX2 6HT
- England, United Kingdom
+44 01865 000000
Oxford Science Enterprises Investments (168)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| First Light Fusion | 14-Feb-2022 | Later Stage VC | 0000 | Energy Production | Generating Revenue | 0000000 0000000 |
| 000 | 20-Jan-2022 | 00000 00000 | 0000 | Discovery Tools (Healthcare) | Generating Revenue/Not Profitable | 000000 00000000 |
| 00000000 | 30-Dec-2021 | 00000 00000 | 000.00 | Network Management Software | Generating Revenue | 0000000 000000 |
| 00000000000 | 15-Dec-2021 | 0000 00000 | 00.000 | Drug Discovery | Startup | 000000 00000 00.0 |
| 0000000 | 15-Dec-2021 | 00000 00000 | 000.00 | Enterprise Systems (Healthcare) | Generating Revenue | 0000000 000000 |
| 00000000 | 12-Oct-2021 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 000000000 | 10-Aug-2021 | 00000 00000 | 000.00 | Decision/Risk Analysis | Generating Revenue | |
| 000000 | 05-Aug-2021 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | 000000 00000000 |
| Endlyz Therapeutics | 29-Jul-2021 | Seed Round | 00.000 | Drug Discovery | Stealth | |
| Rey (Other Healthcare Services) | 27-Jul-2021 | Early Stage VC | 0000 | Other Healthcare Services | Generating Revenue |
Oxford Science Enterprises Exits (10)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Yasa | 22-Jul-2021 | Merger/Acquisition | |
| 000000000 | 30-Apr-2021 | 000 | 00000 |
| 000000000 | 19-Feb-2021 | 0000000000: 000000 | |
| 0000 00000000 | 26-Oct-2020 | 000000000000000000 | 00000 |
| 0000000 | 22-Sep-2020 | 000 00 00000000 | |
| 00000000 | 09-Apr-2020 | 000000000000000000 | |
| 00.00 | 31-Mar-2020 | 000000000000000000 | |
| 000000 00000 | 12-Dec-2019 | 000000000000000000 | |
| Oxtex | 01-Oct-2019 | Bankruptcy: Liquidation | |
| iOx Therapeutics | Merger/Acquisition |
Oxford Science Enterprises Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialOxford Science Enterprises Team (53)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Alexis Dormandy | Chief Executive Officer | 0 | 0 | 0 | Oxford, United Kingdom |
| James Wilkinson | Chief Financial Officer | 0 | 0 | 0 | Oxford, United Kingdom |
| Alexis Zervoglos | Senior Partner, Technology | Oxford, United Kingdom | |||
| Claire Brown Ph.D | Partner, Life Sciences | 0 | 0 | 0 | Oxford, United Kingdom |
| Matthew Arnold | Principal, AI & Software | 00 | 0 | 0 | Oxford, United Kingdom |
Oxford Science Enterprises Co-Investors (155)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Oxford Investment Consultants | 14 | 00 |
|
|
|
| Parkwalk Advisors | 00 | 0 | 0 |
|
|
| University of Oxford | 0 | 0 |
|
|
|
| IP Group | 0 | 0 |
|
|
|
| Oxford University Innovation | 0 | 0 | 0 |
|
|